ADCY3 and obesity due to melanocortin 4 receptor deficiency: Although the role of Adcy3 in humans has yet to be elucidated, our findings raise the possibility that Adcy3 activators may be useful agents for the prevention or treatment of obesity and associated metabolic complications.